SPARC and ocular melanoma: Late osteogenic differentiation of ASCs and SHED was evaluated by quantifying the transcriptional levels of osteopontin (Figure 5A) and osteonectin (Figure 5B) genes, which resulted in more expressed in OM condition at both day 7 and 14.